Intelligent Investor

Mesoblast Limited (ASX: MSB) - Announcements

- Current share price for MSB : $1.085

ASX company news and announcements for Mesoblast Limited (MSB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Mesoblast Limited (MSB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Mesoblast Limited (MSB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Mesoblast Limited (MSB)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$1,239 Agreement signed with Major International Medical Company 24 Aug 2005 10:42AM $0.505 $1.085 $0.795 risen by 114.85%
$1,239 Commitments Test Entity - Fourth Quarter Report 1 Aug 2005 8:31AM $0.440 $1.085 $0.795 risen by 146.59%
$1,239 Colorado State University to Trial for Bone Regeneration 21 Jul 2005 9:08AM $0.500 $1.085 $0.795 risen by 117%
$1,239 Targets United States Investor Base 5 Jul 2005 10:17AM $0.480 $1.085 $0.795 risen by 126.04%
$1,239 Rapid prog towards adult stem cell human clinical trials 31 Mar 2005 8:57AM $0.590 $1.085 $0.795 risen by 83.90%
$1,239 Contract Cell Processing Facility for Pilot Clinical Trials 15 Feb 2005 8:29AM $0.690 $1.085 $0.795 risen by 57.25%

901 - 906 of 906 results

Page 37 of 37

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.